Evidence map›Paper›PMID 34804723›Full record

ArticleCureus2021

Moyamoya Disease in a 13-Month-Old Middle Eastern Boy.

Nashwa M Ali, Abdullah Alawad, Ahmed Alferayan, Ahmed Al-Rumayyan, Sawsan Alkoury

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Nashwa M AliCollege of Medicine, Alfaisal University, Riyadh, SAU.
Abdullah AlawadInterventional Radiology, King Saud Medical City, Riyadh, SAU.
Ahmed AlferayanNeurosurgery, Specialized Medical Center, Riyadh, SAU.
Ahmed Al-RumayyanNeurology, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, SAU.
Sawsan AlkouryPediatrics, Specialized Medical Center, Riyadh, SAU.
King Saud bin Abdulaziz University for Health Sciences · SAAlfaisal University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Moyamoya disease (MMD) is a rare, chronic cerebrovascular disease affecting the cerebral arteries, leading to the development of unique collateral vessels. Few cases were reported from Saudi Arabia; however, the incidence rate is not well-defined. Hence, we present a case of a 13-month-old child who presented to the emergency room with first onset focal seizures with relatively unremarkable past medical and family history. Investigations were ordered accordingly including head computed tomography (CT) scan, brain magnetic resonance imaging (MRI), and cerebral angiogram, and he was diagnosed with MMD and considering a broader variety of differential diagnoses for seizures in children is highlighted in our case. Furthermore, considering their predominance in east Asian countries, it highlights a rare presentation in the middle eastern race.

Indexed as

encephaloduroarteriosynangiosis (edas)moyamoya disease (mmd)moyamoya syndromemripuff of smokeseizure

Identifiers

PMID34804723
PMCPMC8598685
OpenAlexW3207832428

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.